TITLE

World Pneumonia Day - November 2, 2009

PUB. DATE
October 2009
SOURCE
MMWR: Morbidity & Mortality Weekly Report;10/30/2009, Vol. 58 Issue 42, p1184
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the first World Pneumonia Day, November 2, 2009, is being endorsed by major world health, government and advocacy organizations to raise the awareness of the effects of pneumonia globally. Pneumonia kills 2 million of the approximate 10 million of children below 5 years of age who die each year worldwide. Vaccines, antivirals and health interventions are being promoted to help reduce pneumonia deaths globally.
ACCESSION #
45006053

 

Related Articles

  • A DAY TO FOCUS - AND ACT - ON PNEUMONIA. Křížová, Pavla // Central European Journal of Public Health;2009, Vol. 17 Issue 4, p202 

    The article focuses on the first World Pneumonia Day held on November 2, 2009. It was launched to raise awareness about pneumonia which is said to be the leading infection that causes death among children around the world. It is said that the disease can be prevented through bacterial vaccines...

  • Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. Mackenzie, Grant A.; Plumb, Ian D.; Sambou, Sana; Saha, Debasish; Uchendu, Uchendu; Akinsola, Bolanle; Ikumapayi, Usman N.; Baldeh, Ignatius; Usuf, Effua; Touray, Kebba; Jasseh, Momodou; Howie, Stephen R. C.; Wattiaux, Andre; Lee, Ellen; Knoll, Maria Deloria; Levine, Orin S.; Greenwood, Brian M.; Adegbola, Richard A.; Hill, Philip C. // PLoS Medicine;Jan2012, Vol. 9 Issue 1, Special section p1 

    Routine use of pneumococcal conjugate vaccines (PCVs) in developing countries is expected to lead to a significant reduction in childhood deaths. However, PCVs have been associated with replacement disease with non-vaccine serotypes. We established a population-based surveillance system to...

  • Progress Toward Introduction of Haemophilus influenzae type b Vaccine in Low-Income Countries -- Worldwide, 2004--2007.  // MMWR: Morbidity & Mortality Weekly Report;2/15/2008, Vol. 57 Issue 6, p148 

    The article reports on the introduction of haemophilus influenzae type b (Hib) vaccine to low-income countries from 2004 to 2007. Hib is estimated to cause meningitis and severe pneumonia and death in children below five years old. In 2000, the GAVI Alliance began providing financial support for...

  • The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Theodoratou, Evropi; Johnson, Sue; Jhass, Arnoupe; Madhi, Shabir A.; Clark, Andrew; Boschi-Pinto, Cynthia; Bhopal, Sunil; Rudan, Igor; Campbell, Harry // International Journal of Epidemiology;Apr2010 Supplement 1, Vol. 39 Issue suppl_1, pi172 

    Background With the aim of populating the Lives Saved Tool (LiST) with parameters of effectiveness of existing interventions, we conducted a systematic review of the literature assessing the effect of Haemophilus influenzae type b (Hib) and pneumococcal (PC) conjugate vaccines on incidence,...

  • Burden of Severe Pneumonia, Pneumococcal Pneumonia and Pneumonia Deaths in Indian States: Modelling Based Estimates. Farooqui, Habib; Jit, Mark; Heymann, David L.; Zodpey, Sanjay // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    The burden of severe pneumonia in terms of morbidity and mortality is unknown in India especially at sub-national level. In this context, we aimed to estimate the number of severe pneumonia episodes, pneumococcal pneumonia episodes and pneumonia deaths in children younger than 5 years in 2010....

  • New vaccine targets childhood pneumonia. Stephenson, Joan; Stephenson, J // JAMA: Journal of the American Medical Association;11/24/99, Vol. 282 Issue 20, p1905 

    Presents information on a pneumococcal vaccine which targets childhood pneumonia. Type of vaccine; Number of strains of bacteria targeted; Effectiveness of the vaccine; Results of clinical trials.

  • The bacteriology of lower respiratory infections in Papua New Guinean and Australian Indigenous children. HARE, KIM M.; SMITH-VAUGHAN, HEIDI C.; LEACH, AMANDA J. // Papua New Guinea Medical Journal;Sep-Dec2010, Vol. 53 Issue 3/4, p151 

    Indigenous children in Australia and children in Papua New Guinea (PNG) share a high burden of respiratory disease. In PNG the focus has been on pneumonia as a major cause of mortality. While pneumonia incidence remains high in Australian Indigenous children, improved access to better health...

  • Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis. Johansson, Kjell Arne; Memirie, Solomon Tessema; Pecenka, Clint; Jamison, Dean T.; Verguet, Stéphane // PLoS ONE;12/9/2015, Vol. 10 Issue 12, p1 

    Background: Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings. We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for...

  • Validity of using Hospital Episode Statistics data on monitoring disease trends. Elemraid, Mohamed A; Pollard, Kerry; Thomas, Matthew F.; Gennery, Andrew R.; Eastham, Katherine M.; Rushton, Stephen P.; Hampton, Fiona; Singleton, Pauline; Gorton, Russell; Spencer, David A.; Clark, Julia E. // Thorax;Sep2011, Vol. 66 Issue 9, p827 

    A letter to the editor is presented in response to the article "Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008," by E. Koshy and colleagues in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics